FY2026 Earnings Forecast for ALHC Issued By Leerink Partnrs

Key Points

• Leerink Partners has increased their FY2026 earnings per share (EPS) forecast for Alignment Healthcare from $0.08 to $0.13, while the consensus estimate remains significantly lower at ($0.69) per share.
• The company's recent quarterly earnings report showed an EPS of $0.07, exceeding the consensus estimate of ($0.07), with revenue reaching $1.02 billion, representing a 49.0% increase year-over-year.
• Several brokerages have updated their ratings on Alignment Healthcare, with a consensus rating of "Moderate Buy" and an average price target of $17.61, reflecting analysts' positive outlook on the stock.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) - Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for shares of Alignment Healthcare in a research note issued to investors on Wednesday, July 30th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $0.13 per share for the year, up from their prior forecast of $0.08. The consensus estimate for Alignment Healthcare's current full-year earnings is ($0.69) per share. Leerink Partnrs also issued estimates for Alignment Healthcare's FY2027 earnings at $0.45 EPS.

Other analysts have also recently issued reports about the company. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $9.00 to $13.00 in a research report on Thursday. Robert W. Baird increased their price objective on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Stifel Nicolaus increased their price objective on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research report on Tuesday, April 8th. Finally, UBS Group increased their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Four equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $17.61.

Alignment Healthcare Stock Performance

Alignment Healthcare stock traded down $0.81 during mid-day trading on Friday, reaching $12.97. 3,566,563 shares of the company were exchanged, compared to its average volume of 3,659,441. Alignment Healthcare has a twelve month low of $7.92 and a twelve month high of $21.06. The firm's 50-day simple moving average is $13.89 and its two-hundred day simple moving average is $15.33. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.69 and a current ratio of 1.66. The firm has a market cap of $2.57 billion, a PE ratio of -46.32 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The firm had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%. The business's revenue was up 49.0% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.13) EPS.

Insiders Place Their Bets

In other news, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $13.44, for a total transaction of $403,200.00. Following the completion of the transaction, the president directly owned 2,042,899 shares of the company's stock, valued at approximately $27,456,562.56. This represents a 1.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Robert L. Scavo sold 60,000 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $14.60, for a total value of $876,000.00. Following the transaction, the insider directly owned 642,953 shares of the company's stock, valued at approximately $9,387,113.80. This trade represents a 8.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,700,753 shares of company stock valued at $269,911,757. Corporate insiders own 7.00% of the company's stock.

Hedge Funds Weigh In On Alignment Healthcare

Several hedge funds have recently bought and sold shares of the company. Amalgamated Bank increased its stake in Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after purchasing an additional 616 shares in the last quarter. Ballentine Partners LLC increased its stake in Alignment Healthcare by 8.6% in the 1st quarter. Ballentine Partners LLC now owns 11,674 shares of the company's stock valued at $217,000 after purchasing an additional 924 shares in the last quarter. MCF Advisors LLC increased its stake in Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after purchasing an additional 1,011 shares in the last quarter. Cresset Asset Management LLC increased its stake in Alignment Healthcare by 0.6% in the 1st quarter. Cresset Asset Management LLC now owns 287,565 shares of the company's stock valued at $5,354,000 after purchasing an additional 1,797 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Alignment Healthcare by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company's stock valued at $641,000 after purchasing an additional 2,154 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.